更年期症状的变化,比较口服雌激醇与透皮雌激醇
1Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, China.
Climacteric : the journal of the International Menopause Society
|November 9, 2023
概括
口服和通过皮肤传递的雌激素都能有效地缓解更年期症状. 这项研究发现,口服雌激醇酸和透皮雌激醇在缓解更年期症状的有效性或安全性之间没有显著差异.
科学领域:
- 内分泌学 在内分泌学.
- 妇女健康 妇女健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 更年期症状显著影响女性的生活质量.
- 激素治疗,包括雌激素,是治疗更年期症状的常见方法.
- 雌醇的不同施用途径可能提供不同的疗效和安全性.
研究的目的:
- 为了比较口服和透皮雌激素在缓解更年期症状方面的疗效和安全性.
- 用库珀曼更年期指数 (KMI) 和更年期评分表 (MRS) 来评估症状减少.
主要方法:
- 一项随机对照试验,涉及257名绝经妇女.
- 参与者接受了24周的透皮雌激醇 (t-E2) 或口服雌激醇酸 (o-E2V),以及微化孕激素.
- 在基线和4,12和24周使用KMI和MRS进行症状评估.
主要成果:
- 口服和通过皮肤输送的雌激素都显著降低了绝经症状 (p < 0.001).
- 两组之间没有观察到KMI得分的显著差异.
- 虽然MRS得分最初相似,但在12周和24周出现了差异 (p=0.005,p=0.011),症状减少或不良影响没有总体差异.
结论:
- 透皮和口服雌激醇在缓解更年期症状方面表现出相似的有效性.
- 两种注射途径均表现出相似的安全性.
- 口服和透皮雌激素之间的选择可能取决于个体患者的因素和偏好.
相关概念视频
Menopause
174
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
174
Hormonal Regulation of the Menstrual Cycle
406
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
406
Menses Phase
283
The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
283
Disorders of the Female Reproductive System
373
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
373
The Menstrual Cycle
849
The menstrual cycle is a recurrent sequence of changes in the uterine endometrium, specifically its functional layer, the stratum functionalis. This cycle prepares the uterus for potential pregnancy. This cycle typically spans 21–35 days, averaging 28 days, and aligns with the ovarian cycle, regulated by fluctuating levels of ovarian hormones, primarily estrogen and progesterone.
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...
849
Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K


